"Individualise devices to cut Spanish HCV (hospital-acquired hepatitis C) rates":
This article was originally published in Clinica
Spanish hepatologists are calling for all instruments used to explore patients to be "individualised", in order to reduce the incidence of hospital-acquired hepatitis C (HCV) infections, according to El Pais. This is one of the recommendations to emerge from a study by the hepatology unit of Barcelona's Hospital Clinic, which found a 0.27% infection rate (Hepatology, January 2005). This could easily be reduced further if appropriate precautions were implemented, the authors concluded.
You may also be interested in...
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.